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Heterologous expressionThe origins of the RNA silencing pathway are in defense against invading viruses and in response,
viruses have evolved counter-measures to interfere with the host pathway. The p19 protein is
expressed by tombusviruses as a suppressor of RNA silencing and functions to sequester small
RNA duplexes, thereby preventing induction of the pathway. p19 exhibits size-speciﬁc and
sequence-independent binding of its small RNA ligands, binding with high afﬁnity to duplexes
20–22 nucleotides long. p19’s binding speciﬁcity and its ability to sequester small RNAs has made
it a unique protein-based tool for probing the molecular mechanisms of the highly complex RNA
silencing pathway in a variety of systems. Furthermore, protein engineering of this ‘molecular cal-
iper’ promises novel applications in biotechnology and medicine where small RNA molecules are of
remarkable interest given their potent gene regulatory abilities.
Crown Copyright  2013 Published by Elsevier B.V. on behalf of Federation of European Biochemical
society. Open access under CC BY-NC-ND license.1. Introduction
1.1. RNA silencing in antiviral defense
The discovery that double-stranded RNA (dsRNA) in the cell elic-
its sequence-speciﬁc inhibition of gene expression through the RNA
silencing pathway has revolutionized our understanding of endog-
enous gene regulation and host–pathogen interactions (reviewed in
[1]). In this system, endogenous and exogenous dsRNA precursors
are the substrates of RNase III enzymes in the Dicer family, which
generate small RNA duplexes (sRNAs) 21–24 nucleotides (nt) in
length. microRNAs (miRNAs) are endogenous sRNAs with nuclear
precursors that are processed in the cytoplasm [1]. miRNAs are crit-
ical in eukaryotic post-transcriptional gene regulation of nearly all
cellular processes and their aberrant expression is linked to several
disease states in humans, including cancer [2]. In plants and inver-
tebrates, this pathway serves as a critical defense against invading
viruses, and there is increasing evidence that this pathway has anti-
viral roles in vertebrates as well [3,12] (Fig. 1). Plants express sev-
eral Dicer-Like (DCL) enzymes with specialized functions and
DCL4 is the primary enzyme responsible for cleaving dsRNA inter-
mediates or fold-back structures in the viral genome, generating
viral-derived short-interfering RNAs (siRNAs) 21-nt long with 302-nt overhangs and 50 phosphates [4–6]. sRNAs are the effector
molecules of the pathway and are incorporated into a RNA-induced
silencing complex (RISC) through interactions with members of the
Argonaute protein family. Plants express a diversity of Argonaute
proteins, but viral-derived siRNAs are predominantly incorporated
into AGO1 or AGO2 to form the anti-viral RISC effector complex [7–
9]. The sRNA-loaded RISC allows sequence speciﬁc gene silencing of
the target mRNA, primarily through mRNA degradation or inhibi-
tion of translation [3,10].
1.2. Viral suppressors of RNA silencing
To counter the RNA silencing pathway, all plant viruses and sev-
eral insect and mammalian viruses have evolved viral suppressors
of RNA silencing (VSRS) [3,11,12]. VSRS from different viral families
have extraordinary diversity in sequence and structure and employ
distinct mechanisms to interfere with the host RNA silencing path-
way, pointing to their independent evolution [3,13]. Functional
annotation of viral genes as VSRS during infection has lent substan-
tial insight into the mechanisms and signiﬁcance of the RNA silenc-
ing pathway in viral defense [3].
Mechanisms of suppression of RNA silencing vary greatly
among VSRS. Some VSRS interfere directly with the silencing
machinery of the host plant [14], such as the p38 protein of Turnip
Crinkle Virus and the 2b protein of Cucumber mosaic virus, which
both function by interfering with AGO1-mediated gene silencing,
p38 through GW motifs that serve as an Ago ‘hook’ [15,16] and
Fig. 1. The RNA silencing pathway and its suppression by the p19 protein of tombusviruses. Dicer or Dicer-like (DCL) enzymes cleave double-stranded RNA (dsRNA) into
small RNA (sRNA) duplexes 21–24 nucleotides long, which are then incorporated into the RNA-induced silencing complex (RISC), which uses one strand of the duplex to elicit
sequence-speciﬁc gene knockdown through mRNA degradation or inhibition of translation [10]. p19 is a viral suppressor of RNA silencing, which functions by sequestering
viral-derived sRNAs (right) and preventing their incorporation into the RISC complex [30]. Kinetics studies suggest a mechanism of suppression involving a ternary complex
between Dicer, sRNA and p19 [31]. p19 also functions to suppress the pathway by preventing the accumulation of AGO1, a component of anti-viral RISC, by inducing the
accumulation of a host miRNA, miR168, which then downregulates AGO1 expression (left) [59].
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tions with AGO1, they prevent loading of an active RISC complex.
Several VSRS interact with dsRNA, either binding long dsRNA to
prevent Dicer-mediated cleavage (e.g. Flockhouse Virus B2 protein
[17]) or binding siRNAs to prevent active-RISC formation (e.g.
p19 protein of tombusviruses [18,19]). Structural analyses have
demonstrated a fascinating diversity in dsRNA binding strategies
by these proteins, three of which have been determined by X-ray
crystallography in complex with dsRNA, lending insight into the
biochemical basis for their ligand speciﬁcities and afﬁnities (Fig. 2).
It has been suggested that sequestering sRNAs is a general strat-
egy of VSRS to suppress the pathway [20,21], however it is becom-
ing increasingly evident that in vitro sRNA binding activity does
not always contribute to suppressor activity and may be important
for other activities of the protein unrelated to VSRS activity. p19’s
high afﬁnity for sRNA is critical to its function in viral pathogenesis,
since point mutations abrogating binding eliminates its silencing
activity in planta [22–24]. On the other hand, Turnip Crinkle Virus
p38 binds dsRNAs of variable length [20], but its suppressor activ-
ity was completely abrogated by mutating two GW residues
responsible for its interaction with AGO1 [15]. Furthermore, p38
is unlikely to function by sRNA sequestration since its transgenic
expression does not prevent the mobility of siRNAs into neighbour-
ing cells, in contrast to what is observed for Tombusvirus p19 and
Beet Yellow Virus p21 proteins [25,26].
1.3. p19: molecular caliper for small RNA duplexes
The p19 protein is expressed by tombusviruses, positive-sense
single-stranded RNA viruses, at high levels during infection to al-low systemic invasion of the host plant [27]. It is encoded in the
30 proximal open reading frame (ORF) p19, which is embedded in
another ORF that encodes a 22-kDa cell-to-cell movement protein.
[28,29]. The characterization of p19’s role in Tombusvirus patho-
genesis has been previously well reviewed by Scholthof [30]. p19
is the most well studied VSRS and its mechanism of suppression
is quite unique; it sequesters sRNAs and prevents their incorpora-
tion into RISC (Fig. 1) [18,19]. p19 is in competition with Argonaute
proteins for sRNAs but it can not de-program an already loaded
RISC complex [19]. It appears from kinetics studies that p19 efﬁ-
ciently competes for sRNAs through a multiple turnover mecha-
nism, as it exhibits highly reversible binding with a very high
dissociation rate constant (koff = 0.062 ± 0.002 s1) and may possi-
bly intercept RISC formation by forming a ternary complex with
Dicer [31].
Delineating p19’s biochemical properties in vitro have been
instrumental to its application as a tool for probing the RNA
silencing pathway. The reported crystal structures of p19 from
both Tomato Bushy Stunt Virus (TBSV) and Carnation Italian Ring-
spot Virus (CIRV) in complex with a 21-nt sRNA (Fig. 2A) [22,32]
demonstrate how p19 functions as a ‘molecular caliper’ to bind
the sRNA according to the length of the duplex. p19 binds the
sRNA as a dimer with N-terminal helices that clasp the edges of
the duplex and provide stacking interactions between tryptophan
residues and the terminal nucleotides, thereby measuring the
length of the duplex. p19 exhibits sequence-independent binding,
as the binding surface consists of a continuous 8-stranded b-sheet
that forms a concave binding surface, interacting with the sRNA
backbone through hydrogen bonding and electrostatic
interactions.
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Fig. 2. Diversity in structures and mechanism of dsRNA binding among viral suppressors of RNA silencing (VSRS) as determined by X-ray crystallography. (A) Carnation Italian
Ringspot Virus (CIRV) p19 in complex with a 21-nt siRNA demonstrates its sequence-independent and size-speciﬁc binding of sRNAs, where it functions as a dimer to form a 8-
stranded b-sheet binding surface that interacts with one face of the sRNA backbone and N-terminal helices that clasp the ends of the sRNA duplex, with end-capping
interactions provided by conserved tryptophan residues (W39 and W42, highlighted in red) (PDB: 1RPU) [78]. Tomato Bushy Stunt Virus (TBSV) p19 in complex with siRNA
shows a nearly identical binding strategy (PDB: 19RF)[32]. (B) Flockhouse virus (FHV) B2 protein in complex with an 18-bp dsRNA demonstrates its sequence and length-
independent binding of dsRNA, where it functions as a dimer to form a four-helix bundle that interacts with one-face of the sugar-phosphate backbone (PDB: 2AZ70) [17]. (C)
Tomato aspermy virus (TAV) 2b protein (1–69) in complex with a 19 bp siRNA demonstrates its sequence-independent binding of dsRNA, where it functions as a dimer to ﬁt its
a-helical protein backbones into the major groove of the RNA duplex (PDB: 2ZI0) [78]. TAV 2b preferentially binds dsRNA, with some preference for duplex length conferred
by tryptophan stacking interactions with siRNAs (W50, highlighted in red) but also binds long dsRNA with high afﬁnity and dsDNA with weak afﬁnity.
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DCL4 enzyme, as this is the main enzyme involved in plant antivi-
ral defense [6,4]. p19 exhibits the highest afﬁnity reported to date
of a protein for siRNAs, with a dissociation constant of approxi-
mately 0.2 nM [22,31,33]. It exhibits drastically reduced afﬁnity
for siRNAs longer or shorter than 20–22 nt long, does not bind sin-
gle-stranded RNA or DNA, and requires 50 phosphates for high
afﬁnity binding but does not require 30-2 nt overhangs [22]. p19
also binds miRNAs (23 nt) with high afﬁnity both in vivo and
in vitro [24,33–37]. Interestingly, p19 also suppresses RNA silenc-
ing by another mechanism unrelated to sequestration of sRNAs; in
plants p19 expression induces the expression of a host miRNA,
miR168, which reduces levels of AGO1, thereby inhibiting anti-vir-
al RISC formation [59].
p19 has been broadly used as an effective suppresser of RNA
silencing through expression in heterologous systems, including
non-endogenous host plants [24], Drosophila [38], Drosophila em-
bryo extracts [19], as well as human cells [24]. Furthermore, it’s
ability to sequester small RNAs in a variety of systems make it
an ideal probe for examining the role these molecules play in di-
verse biological processes, not limited to host-pathogen interac-
tions. Herein we discuss its application as a probe for small RNAs
in diverse systems as well as the applications of puriﬁed, recombi-
nant p19 proteins in small RNA detection. Furthermore, we discuss
how p19 is amenable to modiﬁcations including protein fusions
and altered binding speciﬁcity, which provide novel properties
and invite further applications of p19 in biotechnology and
therapy.
2. p19 as a tool to probe small RNA pathways
2.1. Probing small RNA biology in plants
Transgenic expression of p19 has allowed interrogation of sRNA
biology in the model plant Arabidopsis thaliana, representing the
largest impact of p19’s use as a probe in heterologous systems.
Examining sRNA accumulation in plants transgenically expressing
cytoplasmic and nuclear variants of p19 gave initial evidence for
nuclear processing of sRNA precursors, as nuclear p19 expression
repressed the accumulation of 21-nt siRNAs and a 21-nt miRNA[39]. Expressing p19 also aided in a landmark study that conﬁrmed
the mobility of 21-nt siRNAs, where the level of suppression of the
mobile interference signal generated from an inverted repeat con-
struct (SUC:SUL) was directly correlated to the extent which p19
had sequestered 21-nt siRNAs [26]. p19’s binding speciﬁcity was
crucial to this experiment; distinguishing between DCL4-gener-
ated 21-nt siRNAs and the long dsRNA precursors and identifying
that the siRNAs are the mobile element.
The details of the siRNA and miRNA pathways in A. thaliana
have been teased apart by applying a ‘molecular toolbox’ approach,
where the diverse properties of VSRS allow interrogation of the
RNA silencing pathway at different points. Transgenic expression
of ﬁve unrelated VSRS in A. thaliana all exhibit silencing activity
but only Turnip mosaic virus (TuMV) P1-HcPro, TBSV p19, and Pea-
nut clump virus (PCV) p15 interfere with the endogenous miRNA
pathway, whereas TCV p38 and Potato virus x p25 are speciﬁc for
the siRNA pathway [24]. The differential effect of these VSRS gave
insight that the siRNA and miRNA pathways in plants are only par-
tially overlapping and that developmental abnormalities associ-
ated with p19 expression are likely due to perturbation of
endogenous miRNA systems [24]. Furthermore, directly comparing
the effect of HcPro, p19, p15 and P38 on siRNA- and miRNA-load-
ing of AGO1 demonstrated that although all VSRS prevented siRNA
loading, only p19 prevented miRNA loading into AGO1, demon-
strating its unique ability to sequester both siRNAs and miRNAs
in vivo. Interestingly, even though TCV p38 interferes directly with
AGO1, it appears to only prevent siRNA loading without affecting
miRNA loading, suggesting that there are two distinct cellular
pools of AGO1 that are loaded with siRNA or miRNA and are differ-
entially targeted by VSRS. By employing VSRS, this study uncovers
another layer of complexity to these intertwined but functionally
distinct pathways [25].
2.2. Probing small RNA biology in Drosophila
p19 has been an effective tool in interrogating the RNA silencing
pathway in Drosophila. It is observed that constitutively expressing
cytoplasmic p19 in living ﬂies impairs hairpin-induced RNAi with-
out altering the endogenous miRNA pathway [40]. Furthermore,
this study effectively employs the ‘molecular toolbox’ approach
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siRNAs to heterochromatin formation in Drosophila; abrogating
the pathway through transiently expressing p19 and FHV B2 in
S2 cells. It was observed that expressing p19 in the nucleus via a
fused nuclear localization signal (NLS-p19) suppressed silencing
of heterochromatin gene markers in adult ﬂies, implicating nuclear
sRNAs in regulating heterochromatin silencing. Examining the
sRNAs bound by p19 through immunoprecipitation determined
that there are abundant endogenous siRNAs (endo-siRNAs) in S2
cells derived from transposable elements. Comparing the sRNA
immunoprecipitates of cytoplasmic p19 versus NLS-p19 demon-
strates the existence of an abundance of cytoplasmic endo-siRNAs
in S2 cells as well as moderately abundant nuclear endo-siRNAs,
and further suggests that a portion of the cytoplasmic endo-siRNAs
are translocated back into the nucleus to elicit chromatin silencing
[40].
2.3. Probing small RNA biology in mammalian cells
p19 has been used to explore the role of RNA silencing in the de-
fense against the retrovirus Primate Foamy Virus type 1 (PFV).
Expressing p19 in human 293T immortalized kidney cells resulted
in a marked increase in viral accumulation, suggesting that sRNAs
were repressing viral replication. It was subsequently shown that
an endogenous miRNA mediates the antiviral defense [41].
p19 was used to probe the sRNA milieu of mouse embryonic
stem cells through immunoprecipitations of transiently expressed
cytoplasmic and nuclear p19 with subsequent small RNA cloning
[42]. This study demonstrated that mouse ES cells do not have
abundant endogenous siRNAs. It was observed that the short
RNAs immunoprecipitated with p19 had an overall higher GC
content than the control RNA, indicated that p19 exhibits a pref-
erence for GC-rich RNA. Additionally, p19 expression in these
cells did not lead to an accumulation of miRNA⁄ strands in cell
extracts, nor were they detected in the p19 immunoprecipitates.
This is in contrast to what has been observed in plants
[24,34,43], suggesting that p19 did not have access to mature
miRNAs in ES cells. Interestingly, it was found that in the absence
of siRNAs, p19 is capable of binding non-canonical ligands in
which a short RNA species annealed to a longer species (32–35
nt) such that the dsRNA region is 19 bp long. The afﬁnity of
p19 for these species was reduced 5–10-fold as compared to
canonical siRNA ligands, but still exhibits nanomolar afﬁnity.
Notably, this study also observes that expressing p19 in HEK293T
cells does not prevent exogenous siRNA-mediated gene
knockdown.
It appears that p19’s ability to suppress RNA silencing in human
cells is not universal. The results in HEK293T cells [42] are consis-
tent with another study where transient expression of p19 in
HEK393T cells did not show an increase in HIV-1 production,
although stable expression of p19 resulted in a modest increase
[44]. Also, we have observed that p19 does not appear to suppress
RNA silencing in human hepatoma cells (Huh7), possibly due to
high levels of endogenous miR-122 that also acts as a ligand for
p19 (unpublished results). These ﬁndings are in contrast to the
effective silencing suppression observed in HeLa cells [24], and
the increased PFV viral accumulation upon p19 expression in
HEK293T cells [41]. This inconsistency in human cells is likely
due to cell-type speciﬁc factors that alter p19’s function, which
have yet to be fully understood.
3. p19 for small RNA detection
Recombinant, puriﬁed p19 proteins invite several applications
in sRNA detection. Fortuitously, p19 is amenable to overexpressionin bacteria with high soluble yields and protein fusions on both the
N- and C-termini retain high afﬁnity for sRNA ligands [19,42,45].
p19’s binding properties allow detection of small RNAs for quanti-
tative analysis, providing sensitive detection without the need for
PCR-based ampliﬁcation. There is widespread interest in increasing
the sensitivity of miRNA detection, given that small changes in
their expression patterns have drastic biological outcomes and
are linked to several disease states [46]. Given p19’s high afﬁnity
for both siRNAs and miRNAs, it is a unique protein-based tool for
sensing sRNAs.
Recombinant CIRV p19 has been used as part of an surface-plas-
mon resonance (SPR) based approach for quantifying miRNA-122
from small RNA isolates of human hepatoma cells, where RNA
probes are immobilized on gold surfaces and p19 detects the miR-
NA-bound probes [36]. This represents a unique strategy that pro-
vides a simple alternative to previous SPR-miRNA detection
methods that require enzymatic surface modiﬁcation and gold
nanoparticle labels for signal ampliﬁcation [47]. p19 has also aided
miRNA detection as part of a rapid enzyme-linked immunoassay
approach which exhibits femtomole sensitivity [36] (Fig. 3A). This
method uses RNA probes conjugated to magnetic microbeads to
capture the target miRNA, which is then bound by p19 allowing ra-
pid detection through horseradish-peroxidase linked antibody
detection of p19. This method achieves high sensitivity of miRNA
detection without the inherent biases that exist in PCR-based
ampliﬁcation [48].
The p19 protein has been used to enhance miRNA detection by
capillary electrophoresis (CE). CE is a rapid and sensitive method
for miRNA detection, however previous research has shown that
a lack of separation between the excess single-stranded probe
and the probe:miRNA duplex precludes accurate quantitative anal-
ysis [49]. p19’s binding speciﬁcity allows enhanced separation be-
tween the probe and probe:miRNA duplex, in a technique termed
protein-facilitated afﬁnity capillary electrophoresis (proFACE)
[37]. Furthermore, this study employed p19 as a tool to improve
miRNA detection in human serum. miRNAs are present in stable
forms in human serum and are being investigated as cancer bio-
markers [50,51]. Commercially available p19-coated beads [52]
were applied to plasma to pre-concentrate probe:RNA duplexes
allowing very sensitive detection (0.5 fM or 30000 miRNA mole-
cules per ml) without requiring PCR ampliﬁcation [37] (Fig. 3B).
p19 has also been applied to ﬂuorescent detection of sRNAs,
where a fusion of a linked p19 dimer and a cyan ﬂuorescent protein
(CFP) allows reporting on binding of ﬂuorescently labeled siRNA
through Förster resonance energy transfer (FRET) [45] (Fig. 3C).
These results suggest the possibility of developing p19 as an intra-
molecular FRET probe to allow sensing of unlabeled siRNA, which
would allow label-free reporting on p19 binding sRNA. This is a
strategy that our lab has been exploring.
4. Modifying p19 for novel properties
Mutational analysis of Tombusvirus genomes has allowed char-
acterization of p19’s role in viral pathogenesis and speciﬁc target-
ing of siRNA binding sites has allowed correlating its siRNA
binding activity to its activity as a VSRS [22,23,53,54]. Mutational
analysis of p19 has produced loss-of-function point mutations
that are useful as negative control constructs. Other mutations
confer altered binding speciﬁcity and suppressor activity, attract-
ing novel applications in biotechnology and human disease re-
search. p19 has been shown to be amenable to mutation and
modiﬁcations, although it is clear that it awaits much broader
experimentation that will likely produce distinct properties use-
ful for dissecting the RNA silencing pathway in diverse
organisms.
Fig. 3. Applications of p19 in small RNA detection. (A) p19 binds probe:miRNA duplexes for quantifying levels of speciﬁc miRNAs in biological samples using bioluminescence
detection of p19 [36]. (B) p19 fusion protein with N-terminal maltose-binding protein and C-terminal chitin binding domain (MBP-p19-CBD) allows enrichment of sRNAs
using chitin magnetic beads (New England Biolabs). Sensitive and quantitative detection of speciﬁc miRNAs in human serum by capillary electrophoresis (CE) is attained
through pre-concentrating miRNA:probe duplexes using p19-coated beads as well as CE stacking, resulting in 1000-fold enrichment of miRNAs and detection as low as
0.5 fM miRNA without PCR-based ampliﬁcation [37]. p19 further aids the analysis by enhancing separation of the probe:miRNA duplexes from the excess, unbound probe, a
technique termed ProFACE (protein-facilitated CE). (C) A C-terminal cyan-ﬂuorescent protein (CFP)-p19 fusion protein detects ﬂuorophore (DY547) labeled siRNA through
Forster resonance energy transfer (FRET), allowing spectrophotometric detection of binding and determination of binding afﬁnity which is amenable to high-throughput
screening applications [45].
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Loss-of-function point mutations abrogating speciﬁc properties
of p19 are of great use as control proteins to compare the effect of
wild-type p19 in various heterologous systems. p19’s interface be-
tween the N- and C-terminal sub-domains appears particularly
sensitive to mutation, where disrupting key salt bridges that stabi-
lize the N-terminal reading heads abrogate siRNA binding and sup-
pressor activity. Two of these mutants, TBSV R72G and RR75–78GG
are incapable of binding siRNAs in planta and do not function as
suppressors, although it has been suggested that these mutations
likely cause structural perturbations that may affect protein stabil-
ity [22,23,53,54]. Recombinant CIRV Y73S has been shown in vitro
to completely abrogate siRNA and miRNA binding and displays a
conformational change from wild-type, as determined by an al-
tered circular dichroism spectrum below 210 nm. Thermal melt
analysis demonstrated that this mutant exhibits a higher Tm, pos-
sibly reﬂecting a more rigid conformation that is not conducive to
ligand binding [33]. All of the mutants from this interface region,
however, still maintain the ability to form dimers [33,54].
Another loss-of-function mutant is generated by directly target-
ing the end-capping tryptophans required for measuring the length
of the sRNA duplex. Mutating the highly conserved Trp39 to gly-
cine in CIRV p19 abrogated its suppressor activity in planta but
was not analyzed for ligand binding activity [22]. We have ob-
served that this mutant’s ability to bind siRNAs in vitro is substan-
tially reduced, but still binds with 100 nM afﬁnity (unpublished
results) and molecular dynamics studies predict a loss in afﬁnity
of 7 kcal/mol [55]. These mutants reﬂect that p19’s binding activ-
ity and thus its suppressor activity can be tailored through modiﬁ-cations to the binding site, and can be used during
experimentation in parallel with wild-type p19 to examine the ef-
fect of sRNA sequestration on cellular processes.
4.2. Altering p19’s effect on endogenous processes
During viral infection, p19’s main role is in binding vsRNAs and
inhibiting the formation of anti-viral RISC, however p19 is also
interacting with and effecting host cell endogenous processes.
Developing p19 as a tool requires that we also understand its effect
on host cellular processes that are not linked to its ability to
sequester sRNAs. p19 interacts with host ALY proteins in planta
through their RNA-binding domain, altering their localization from
the nucleus to the cytoplasm [56,57]. p19 also alters HEN-1 medi-
ated miRNA methylation and therefore affects miRNA stability
[58]. In plants, p19 appears to speciﬁcally enhance the level of
miR168 which downregulates the levels of endogenous AGO1,
but this activity may be distinct from its ability to bind sRNAs
[59]. Little is known regarding p19’s interactions with host factors
in other organisms, and will need to be examined to broaden p19’s
application, but will also highlight differences between RNA silenc-
ing pathways in different species.
During heterologous expression of p19, it is evident that its ef-
fect on endogenous processes is often detrimental to the host.
Exploring the biochemical basis for its symptomatic effects, includ-
ing viral-like symptoms and developmental defects, have impli-
cated its interactions with the host miRNA pathways [60,61]. p19
expression in A. thaliana stabilizes miRNA/miRNA⁄ duplexes there-
by decreasing the activity of the template strand [24,34,43] and
has been demonstrated in planta to prevent miRNA loading into
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has been attributed to misregulation of miR167 target AUXIN RE-
SPONSE FACTOR 8 (ARF8) in Arabidopsis [61]. Interestingly, trans-
genically expressing p19 and other VSRS in Drosophila does not
cause the developmental delays and does not alter endogenous
miRNA pathways, possibly inviting more applications in this
organism [38].
By dissecting p19’s effect in these systems we can begin to
hypothesize how to overcome detrimental effects to the host while
still allowing p19 to function as a suppressor protein. Intriguingly,
mutational analysis of p19 suggests that its ability to bind sRNA
and its other biological effects may be functionally separated. Spe-
ciﬁc targeting of the siRNA-binding sites of TBSV p19 generated
several mutants unable to bind siRNA, and it was observed that
targeting different regions of the protein gave distinct, host-spe-
ciﬁc biological outcomes not attributable to siRNA binding [23].
It was suggested that these mutations might alter p19’s effect on
other host factors, including miRNAs, although this remains to be
explored experimentally.
One particular mutant of TBSV p19, R43W, displays attenuated
symptomatic effects during viral infection but still displays activity
as a suppressor of RNA silencing and binds siRNAs in planta, albeit
reduced from wild-type levels [53,54]. Interestingly, this mutant
binds longer dsRNA molecules in planta and its altered binding
speciﬁcity is possibly due to an inability to form a hydrogen bond
with the 50 phosphate of a sRNA [54]. Due to its lowered symptom-
atic effects, R43W p19 was applied in a heterologous expression
system to increase foreign gene expression in A. thaliana [62].
Wild-type p19 can be transiently co-expressed with a foreign gene
of interest and substantially increase foreign gene expression
(50-fold) [63] and has been applied to increase the expression
of several foreign genes of interest for vaccine development, such
as HIV and SARS antigens [64,65], as well as therapeutic antibodies
[66,67]. Generating p19-expressing stably transformed plants,
however, is hampered by its toxicity [68]. Applying the less symp-
tomatic mutant p19, R43W, results in 7-fold increase in GFP
expression when transiently expressed, although stable expression
results in a modest 1.7-fold increase [62]. It is possible that this
mutant is impaired in its normal ability to target host processes,Fig. 4. Engineering the p19 protein for enhanced function and altered binding speciﬁci
using a semi-rigid linker (GGGS)2 between the ﬂexible N-terminus of one monomer a
enhanced binding afﬁnity for siRNA and enhanced thermal stability [69]. (B) Site-direct
afﬁnity interactions with the human microRNA, miR-122, resulting in a 50-fold enhancem
the binding site better accommodates the bulges in the miR-122 molecule and generatesuch as the miRNA pathway, although these important questions
remain to be experimentally validated. This study provides
proof-of-concept that p19 can be modiﬁed towards effective
silencing activity with lowered symptomatic effects. R43W may
serve as a platform from which further modiﬁcations can be made
to further uncouple the unwanted symptomatic effects while
retaining suppressor activity.
It is important to note that the majority of the mutational
analysis performed thus far on p19 sequences has been during
the context of viral infection, which has limited scope since the
entire p19 gene is embedded within another ORF. We suggest
that to optimize p19 as a tool in heterologous systems, more
comprehensive mutational analyses performed with recombinant
sequences may result in distinct outcomes desirable in different
systems. For example, using recombinant CIRV p19 we observe
that p19’s afﬁnity for a human miRNA can be increased 50-fold
through a single point mutation without altering its afﬁnity for
siRNA in vitro (discussed below). Through engineering efforts it
may be possible to functionally separate its activity as a suppres-
sor from its interference with endogenous processes that preclude
its broader application.
4.3. Enhancing function
Recombinant CIRV p19 has been modiﬁed for enhanced func-
tion through protein engineering for applications in biotechnology
and human therapy. Linking the two monomers through a semi-ri-
gid linker (GGGGS)2 between the N-terminus of one monomer and
the C-terminus of the other monomer enhances the thermal stabil-
ity of the construct and it’s afﬁnity for siRNA 3.5-fold over wild
type p19 [69] (Fig. 4A). Having a linked p19 dimer construct facil-
itates its use in biotechnology and has been used for quantitative
miRNA detection using ProFACE [37]. Mutagenesis studies explor-
ing the importance of cysteine residues in the p19 protein led to
the observation that mutating three cysteine residues (C110,
C134 and C160) to isoleucine results in improved solubility proper-
ties, precluding the need for reducing agents during puriﬁcation
and storage, as is required for puriﬁcation of wild type p19 proteins
to prevent aggregation (unpublished results) [70].ty. (A) Recombinant CIRV p19’s properties are enhanced by linking the monomers
nd the C-terminus of the other monomer. The linked dimer exhibits a 3.5-fold
ed mutagenesis of a single residue of the p19-binding site generates unique high-
ent in binding afﬁnity. By mutating threonine 111 to serine, a potential ‘pocket’ in
s new hydrogen bonding interactions [33].
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Novel applications of mutant p19 proteins are forthcoming, as
there is evidence that mutations in its binding site can alter its
binding speciﬁcity for certain molecules. p19 exhibits highest
afﬁnity for perfectly base paired sRNA duplexes. Wild-type p19’s
afﬁnity for a human miRNA, miR-122, is 100 fold less than its
afﬁnity for a perfectly base paired duplex [33]. miR-122 is a li-
ver-speciﬁc miRNA [71] which is used by the hepatitis C virus to
aid in the viral life cycle [72–74] and whose sequestration is being
investigated for human therapy [75].
Mutating a single residue in the binding site of recombinant
CIRV p19, Thr111 to serine (T111S) increases its afﬁnity for the hu-
man miRNA, miR-122, 50-fold and allows sequestering the miRNA
in human hepatoma cells [33] (Fig. 4B). Interestingly, the T111S
mutation did not alter the protein’s afﬁnity for siRNA, suggesting
that there are unique interactions between p19’s binding site and
miR-122 versus the siRNA, which are likely due to structural devi-
ations in the miRNA from base-pair mismatches. By mutating
Thr111 to serine, there appears to be novel hydrogen-bond interac-
tions with the miR-122 molecule, allowing high afﬁnity binding
that may be speciﬁc to its areas of base pair mismatches. Interest-
ingly, another study notes that p19’s afﬁnity for another miRNA,
let-7, was the same as its afﬁnity for siRNA [31]. It is possible that
certain positions of mismatches cause more potent disruptions in
p19’s binding.
These studies suggest that it may be possible to tailor the p19
binding site to bind speciﬁc types of molecules with high afﬁnity,
perhaps through enhancing interactions with ‘bulges’ in miRNAs.
The positioning of mismatches in miRNAs is increasingly recog-
nized for speciﬁc biological effects. Certain Argonaute proteins ex-
hibit speciﬁcity based on mismatch placement [76] and transitivity
in plants also depends on miRNA mismatches [77]. This is a bur-
geoning ﬁeld in protein:RNA interactions, and the unique features
of the p19 binding site among RNA binding proteins make it an
excellent platform for further development as a tool in
biotechnology.
5. Perspectives
Understanding the mechanisms of the RNA silencing pathway is
essential for research into human disease states, among a multi-
tude of other areas, and is prerequisite to its manipulation for
desirable outcomes in therapy and biotechnology. The evolution-
ary arms race between hosts and pathogens has given us a unique
set of proteins that potently abrogate RNA silencing and whose
characterization has produced fundamental knowledge of this
pathway in diverse organisms. The greatest beneﬁt will come
now from expanding this repertoire through protein engineering
of these VSRS. The tombusviral p19 protein has been demonstrated
to be a unique tool for small RNA sequestration in living systems
and protein engineering efforts will likely lead to ﬁne-tuning of
its ligand speciﬁcity and biological effects, thus inviting broader
application.
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